Patricia Kovatch
- ASSOCIATE DEAN FOR SCIENTIFIC COMPUTING
- SENIOR FACULTY Genetics and Genomic Sciences
- SENIOR FACULTY Structural and Chemical Biology
Print Profile
Training Areas
Biography
Ms. Kovatch has been the Associate Dean for Scientific Computing at the Mount Sinai School of Medicine since October 2011. She is responsible for achieving the School’s high-performance computing (HPC) goals, which are critical to the advancement of the School's research enterprise, filling an essential role by ensuring the efficient and effective delivery and maintenance of computational resources. Since joining the School, she has deployed a 7,000 core, high-performance cluster with 1.5Pbyte of shared disk space, which is already fully utilized by the School's genomic and biomedical research programs. She has also led a statewide collaboration to upgrade network infrastructure to accelerate data-intensive science with broad community benefit. In addition, she manages the Data Warehouse and the Research Information Technology groups.
Prior to joining Mount Sinai, Ms. Kovatch spent four years as a leader in HPC at the National Institute for Computational Sciences (NICS) of the University of Tennessee, Knoxville, located at Oak Ridge National Laboratory. She established a $75 million computational science center at NICS and attracted an additional $35 million in funding. While at NICS, Ms. Kovatch deployed the world's third fastest machine in November 2009, a 1.17 petaflop Cray XT5, with 112,896 cores and 147 terabytes of memory that delivers over 60 percent of all computational cycles to National Science Foundation users.
Her previous positions at the University of California, San Diego, and the University of New Mexico involved the design, deployment, and management of HPC programs and teams. Ms. Kovatch has been principal investigator on several National Science Foundation computational projects. She has been invited to present on her work at professional conferences nationally and internationally, and has multiple publications in high-performance computing.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Kovatch did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.